Inverted-T Incision With Early Apical Release vs. Three-Lobe in Holmium Laser Enucleation of The … (NCT07642063) | Clinical Trial Compass
By InvitationNot Applicable
Inverted-T Incision With Early Apical Release vs. Three-Lobe in Holmium Laser Enucleation of The Prostate
Egypt140 participantsStarted 2026-03-20
Plain-language summary
Aim of the work is to compare the surgical efficacy and perioperative outcomes of the inverted-T incision with early apical release technique versus the standard three-lobe technique in patients undergoing Holmium Laser Enucleation of The prostate for Benign prostatic hyperplasia .
Primary outcome :
* Technical operative time (started from the activation of the holmium laser for enucleation of the prostate lobes and ending after completion of morcellation )
Secondary outcome:
* Laser energy used.
* Intraoperative blood loss (change in hemoglobin level).
* Learning curve.
Who can participate
Age range
50 Years – 80 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male patients aged 50-80 years.
* Prostate size ≥ 80 mL.
* Candidates for Holmium Laser Enucleation of the Prostate based on clinical and radiological evaluation
Exclusion Criteria:
* Suspected or confirmed prostate cancer.
* Previous prostate or urethral procedure (excluding prostate biopsy).
* Urethral stricture.
* Active urinary tract infection.
* Urinary bladder mass, stone or diverticulum.
* Severe coagulopathy or inability to discontinue anticoagulant/antiplatelet medications.
* Unwillingness to comply with follow-up protocol
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.